5fp0: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
 
Line 3: Line 3:
<StructureSection load='5fp0' size='340' side='right'caption='[[5fp0]], [[Resolution|resolution]] 2.35&Aring;' scene=''>
<StructureSection load='5fp0' size='340' side='right'caption='[[5fp0]], [[Resolution|resolution]] 2.35&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[5fp0]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FP0 OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5FP0 FirstGlance]. <br>
<table><tr><td colspan='2'>[[5fp0]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FP0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5FP0 FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=SZC:N-CYCLOPENTYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-3H-BENZIMIDAZOLE-4-SULFONAMIDE'>SZC</scene></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.35&#8491;</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5fp0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fp0 OCA], [http://pdbe.org/5fp0 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5fp0 RCSB], [http://www.ebi.ac.uk/pdbsum/5fp0 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5fp0 ProSAT]</span></td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=SZC:N-CYCLOPENTYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-3H-BENZIMIDAZOLE-4-SULFONAMIDE'>SZC</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5fp0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fp0 OCA], [https://pdbe.org/5fp0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5fp0 RCSB], [https://www.ebi.ac.uk/pdbsum/5fp0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5fp0 ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
[[http://www.uniprot.org/uniprot/HYES_HUMAN HYES_HUMAN]] Bifunctional enzyme. The C-terminal domain has epoxide hydrolase activity and acts on epoxides (alkene oxides, oxiranes) and arene oxides. Plays a role in xenobiotic metabolism by degrading potentially toxic epoxides. Also determines steady-state levels of physiological mediators. The N-terminal domain has lipid phosphatase activity, with the highest activity towards threo-9,10-phosphonooxy-hydroxy-octadecanoic acid, followed by erythro-9,10-phosphonooxy-hydroxy-octadecanoic acid, 12-phosphonooxy-octadec-9Z-enoic acid, 12-phosphonooxy-octadec-9E-enoic acid, and p-nitrophenyl phospate.<ref>PMID:12574508</ref> <ref>PMID:12574510</ref>
[https://www.uniprot.org/uniprot/HYES_HUMAN HYES_HUMAN] Bifunctional enzyme. The C-terminal domain has epoxide hydrolase activity and acts on epoxides (alkene oxides, oxiranes) and arene oxides. Plays a role in xenobiotic metabolism by degrading potentially toxic epoxides. Also determines steady-state levels of physiological mediators. The N-terminal domain has lipid phosphatase activity, with the highest activity towards threo-9,10-phosphonooxy-hydroxy-octadecanoic acid, followed by erythro-9,10-phosphonooxy-hydroxy-octadecanoic acid, 12-phosphonooxy-octadec-9Z-enoic acid, 12-phosphonooxy-octadec-9E-enoic acid, and p-nitrophenyl phospate.<ref>PMID:12574508</ref> <ref>PMID:12574510</ref>  
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 25: Line 26:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Human]]
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Backstrom, S]]
[[Category: Backstrom S]]
[[Category: Beisel, H G]]
[[Category: Beisel HG]]
[[Category: Johansson, C A]]
[[Category: Johansson CA]]
[[Category: Karis, D]]
[[Category: Karis D]]
[[Category: Olsson, T]]
[[Category: Olsson T]]
[[Category: Oster, L]]
[[Category: Oster L]]
[[Category: Rohman, M]]
[[Category: Rohman M]]
[[Category: Xue, Y]]
[[Category: Xue Y]]
[[Category: Hydrolase]]